Tag Archives: ZIOP

Top 5 Safest Stocks To Own Right Now

Numis Securities cut shares of Safestore (LON:SAFE) to a hold rating in a report published on Thursday morning.

Several other research analysts also recently issued reports on the stock. Liberum Capital reissued a buy rating and set a GBX 560 ($7.46) price objective on shares of Safestore in a research report on Thursday, February 22nd. Peel Hunt reissued a hold rating on shares of Safestore in a research report on Thursday, April 5th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has an average rating of Buy and an average target price of GBX 540.83 ($7.20).

Get Safestore alerts:

Safestore opened at GBX 556.50 ($7.41) on Thursday, MarketBeat Ratings reports. Safestore has a 1-year low of GBX 360 ($4.79) and a 1-year high of GBX 528 ($7.03).

Top 5 Safest Stocks To Own Right Now: First Financial Northwest Inc.(FFNW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Financial Northwest (FFNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Safest Stocks To Own Right Now: Coinstar Inc.(CSTR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Capstar Financial (NASDAQ: CSTR) and Mercantile Bank (NASDAQ:MBWM) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

  • [By Joseph Griffin]

    Shares of Capstar Financial Holdings Inc (NASDAQ:CSTR) have been assigned an average rating of “Hold” from the five research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $19.75.

Top 5 Safest Stocks To Own Right Now: Celgene Corporation(CELG)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Stock No. 1: The first one up, alphabetically, is Celgene (NASDAQ:CELG). The ticker symbol is CELG. Celgene, two years ago, was at $101 a share. Celgene, as of Monday’s market close was down to $84.57. So, not such a great stock pick of mine. Celgene down 16%. The market up 30%. So, we’re going to have to log a minus 46% to start this review of my stocks from five years ago, as Celgene has dropped a little and the market, as we’ve already established, has done quite well.

  • [By ]

    Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .

  • [By Logan Wallace]

    Celgene (NASDAQ:CELG) announced that its Board of Directors has approved a stock repurchase program, which allows the company to buyback $3.00 billion in shares on Thursday, May 24th. This buyback authorization allows the biopharmaceutical company to buy up to 5.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

  • [By Keith Speights]

    There’s room for debate, of course. But in my view, three deals especially stand out. Here’s why I rank Celgene’s (NASDAQ:CELG) buyout of Juno Therapeutics, Novartis’ (NYSE:NVS) acquisition of AveXis, and Roche’s (NASDAQOTH:RHHBY) purchase of Foundation Medicine (NASDAQ:FMI) as the best biotech acquisitions of 2018 (so far).

  • [By Paul Ausick]

    Celgene Corp. (NASDAQ: CELG) dropped about 1.8% Friday to post a new 52-week low of $78.51. Shares closed at $79.98 on Thursday and the stock’s 52-week high is $147.17. Volume of around 5.4 million shares was about 20% below the daily average. The company was one of several named Thursday in an FDA report of drugmakers who may be illegally blocking delaying access to cheaper generic copies of brand-name drugs.

  • [By Ethan Ryder]

    Sumitomo Mitsui Trust Holdings Inc. increased its holdings in Celgene (NASDAQ:CELG) by 3.9% during the first quarter, HoldingsChannel.com reports. The fund owned 2,379,884 shares of the biopharmaceutical company’s stock after buying an additional 89,641 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Celgene were worth $212,309,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 5 Safest Stocks To Own Right Now: PAREXEL International Corporation(PRXL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Safest Stocks To Own Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Keith Speights]

    If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm’s share price has dropped more than 25% so far in 2018, while Celldex stock has plunged more than 80%.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

  • [By Keith Speights]

    Ziopharm Oncology Inc. (NASDAQ:ZIOP) shareholders have been on a roller coaster ride this year. The stock soared 16% in May, but the ride promptly went downhill in June, with the biotech’s share price dropping more than 10%. The first four months of 2018 featured more of the same up-and-down action.

  • [By Todd Campbell]

    After disclosing that the Food and Drug Administration is asking for more information before signing off on a phase 1 study of its “Sleeping Beauty” CAR-T for leukemia and lymphoma, shares in Ziopharm Oncology (NASDAQ:ZIOP) were tumbling 17.7% at 3 p.m. EDT today.

Top 10 Casino Stocks To Invest In Right Now

Last weekend I enjoyed a wonderful stay at the Mirage Hotel and Casino in Las Vegas, Nevada. Its right on the Vegas Strip, famous for its world-class casinos.

I wasnt there to gamble however.

My reason for being in Vegas was to see whats going on in the booming cannabis industry.

My goal was to attend the largest cannabis trade show of the year and find the next best moneymaking opportunities for you.

Believe me when I say it. Theres a ton of opportunity out there.

Marijuana is Big Business

Hundreds of exhibitors were on display.

I talked to a number of entrepreneurs and investors about the latest developments in this budding industry. All with a focus on finding the best investment opportunities.

Needless to say its been a lot of fun!

Whats really astonishing though is how big this industry has become.

Top 10 Casino Stocks To Invest In Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Keith Speights]

    If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm’s share price has dropped more than 25% so far in 2018, while Celldex stock has plunged more than 80%.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

Top 10 Casino Stocks To Invest In Right Now: Covanta Holding Corporation(CVA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    HL Financial Services LLC trimmed its holdings in shares of Danielson Holding Co. (NYSE:CVA) by 12.3% in the first quarter, HoldingsChannel reports. The firm owned 49,434 shares of the energy company’s stock after selling 6,964 shares during the quarter. HL Financial Services LLC’s holdings in Danielson were worth $717,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Danielson (NYSE: CVA) and MGE Energy (NASDAQ:MGEE) are both oils/energy companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

  • [By Lee Jackson]

    This company has seen solid insider buying over the past year. Covanta Holding Corp. (NYSE: CVA) is a world leader in providing sustainable waste and energy solutions. Annually, Covanta’s modern energy-from-waste facilities safely convert approximately 20 million tons of waste from municipalities and businesses into clean, renewable electricity to power 1 million homes and recycle approximately 500,000 tons of metal.

Top 10 Casino Stocks To Invest In Right Now: Gap, Inc. (GPS)

Advisors’ Opinion:

  • [By ]

    For an “Executive Decision” segment, Cramer sat down with Art Peck, president and CEO of Gap Inc. (GPS) , the bricks-and-mortar retailer that saw its shares rise over 50% last year, only to slip this year, down 9%.

  • [By Jim Crumly]

    As for individual stocks, retail earnings reports continue to produce winners and losers in the market, with Foot Locker (NYSE:FL) rising higher on its profit outlook and TheGap, Inc. (NYSE:GPS) stumbling due to softening in its core brand.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on GAP (GPS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Douglas A. McIntyre]

    Gap Inc. (NYSE: GPS) has been through a series of strategic retreats over the past several years, closing hundreds of stores. Its most recent earnings report shows it still may have too many stores, at least for its flagship brand.

  • [By Leo Sun]

    Shares of Gap (NYSE:GPS) tumbled 15% on May 25, after the apparel retailer posted mixed first-quarter results. Its revenue rose 10% year over year to$3.78 billion, beating estimates by $180 million. Its comparable-store sales rose 1%, marking its sixth straight quarter of comps growth.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

Top 10 Casino Stocks To Invest In Right Now: Sibanye Gold Limited(SBGL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Zoe's Kitchen, Inc. (NYSE: ZOES) fell 27.8 percent to $10.45 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company also lowered its FY18 sales outlook from $358million-$368 million to $345 million-$352 million.
    Hibbett Sports, Inc. (NASDAQ: HIBB) shares fell 15.6 percent to $24.50 in pre-market trading after the company reported weaker-than-expected results for its first quarter.
    Rockwell Medical, Inc. (NASDAQ: RMTI) fell 15.5 percent to $5.02 in the pre-market trading session after the company disclosed that its President and CEO Robert Chioini was terminated.
    BG Staffing Inc (NYSE: BGSF) shares fell 12.7 percent to $19.00 in pre-market trading after reporting a common stock offering.
    8×8, Inc. (NASDAQ: EGHT) fell 9.3 percent to $20.00 in pre-market trading after reporting downbeat quarterly earnings.
    Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) fell 7.7 percent to $2.35 in pre-market trading after rising 3.88 percent on Thursday.
    Gap, Inc. (NYSE: GPS) shares fell 7.5 percent to $30.49 in pre-market trading after the company posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter.
    California Resources Corporation (NYSE: CRC) fell 6.4 percent to $33.91 in pre-market trading.
    Buckle Inc (NYSE: BKE) fell 4.9 percent to $24.50 in pre-market trading following weak quarterly sales.
    China Rapid Finance Limited (NYSE: XRF) shares fell 4.9 percent to $3.13 in pre-market trading after climbing 11.53 percent on Thursday.
    Ross Stores, Inc. (NASDAQ: ROST) fell 4.8 percent to $78.98 in pre-market trading. Ross Stores reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter.
    Callon Petroleum Company (NYSE: CPE) shares fell 4.7 percent to $11.90 in pre-market trading after the company reported pricing of common

  • [By Paul Ausick]

    Sibanye Gold Ltd. (NYSE: SBGL) traded down about 8.3% Monday and posted a new 52-week low of $3.66 after closing Friday at $3.99. The stock’s 52-week high is $10.60. Volume totaled around 7.5 million, about double the daily average. The company had no specific news..

  • [By Logan Wallace]

    Shares of Sibanye Gold Ltd (NYSE:SBGL) have been assigned a consensus rating of “Buy” from the seven brokerages that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Sibanye Gold Ltd (SBGL) Receives Average Recommendation of “Buy” from Analysts” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/3364474/sibanye-gold-ltd-sbgl-receives-average-recommendation-of-buy-from-analysts.html.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Restoration Robotics Inc (NASDAQ: HAIR) fell 19.8 percent to $3.45 in pre-market trading after reporting a first-quarter earnings miss.
    Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.2 percent to $3.80 in pre-market trading after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million.
    Vipshop Holdings Limited (NYSE: VIPS) fell 15.9 percent to $12.70 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter on Monday.
    Aptose Biosciences Inc. (NASDAQ: APTO) shares fell 11 percent to $2.98 in pre-market trading after climbing 2.45 percent on Monday.
    Sibanye Gold Limited (NYSE: SBGL) shares fell 8 percent to $2.91 in pre-market trading after surging 6.40 percent on Monday.
    Switch Inc (NYSE: SWCH) shares fell 7.2 percent to $14.36 in pre-market trading following a first-quarter earnings miss.
    Agilent Technologies, Inc. (NYSE: A) fell 7.1 percent to $64.31 in pre-market trading following mixed Q2 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) fell 5.8 percent to $10.50 in pre-market trading after rising 25.22 percent on Monday.
    Carbon Black, Inc. (NASDAQ: CBLK) shares fell 5.1 percent to $22.46 in pre-market trading.
    Home Depot Inc (NYSE: HD) fell 2.4 percent to $186.65 in pre-market trading. Home Depot reported better-than-expected earnings for its first quarter, while sales missed estimates

  • [By Lisa Levin]

     

    Losers
    Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results.
    Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results.
    SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss.
    Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday.
    Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million.
    Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today.
    ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79.
    Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss.
    Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss.
    iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results.
    Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97.
    Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15.
    AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings.
    Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49.
    Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday.
    Myomo, Inc. (NYSE: MYO) slipp

Top 10 Casino Stocks To Invest In Right Now: Sears Holdings Corporation(SHLD)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    Shares ofSears Holding Corp(NASDAQ:SHLD) were selling off again today after the struggling retailer posted a disappointing first-quarter earnings report and announced it would close even more stores. Sales continued to tumble in the period and, its bottom-line loss widened, another sign of the dire straits the company finds itself in. As of 11:26 a.m. EDT, the stock was down 9.7%.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment.
    Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores.
    Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design.
    Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter.
    Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering.
    Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million.
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday.
    Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2

  • [By Adam Levine-Weinberg]

    Shares of Sears Holdings (NASDAQ:SHLD) bounced higher on Monday after the struggling retail icon announced that a special committee of its independent directors would evaluate the potential sale of several assets. This was the second time in the span of a week that Sears stock shot higher based on a major strategic announcement. (The first was the news that the Sears Auto Center business would team up with Amazon.com to sell and install tires.)

Top 10 Casino Stocks To Invest In Right Now: Donegal Group, Inc.(DGICB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Donegal Group (NASDAQ:DGICB) have been trending somewhat positive on Thursday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Donegal Group earned a news impact score of 0.13 on Accern’s scale. Accern also assigned news stories about the insurance provider an impact score of 47.2596177658095 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 10 Casino Stocks To Invest In Right Now: Wolverine World Wide, Inc.(WWW)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    While that is happening in the Middle East, trouble is brewing in Washington. In addition to reports that a Russian Oligarch paid Trump’s lawyer $500,000, a U.S. telecom giant is now caught up with the same lawyer. AT&T Corporation (NYSE: T) confirmed Tuesday night that it paid Trump lawyer Michael Cohen for information on the administration. AT&T stock is up 0.6% in premarket hours.
    Four Stocks to Watch Today: TRIP, MTCH, FOXA, DIS
    Shares of TripAdvisor (Nasdaq: TRIP) popped nearly 20% after the company crushed earnings after the bell. In addition, the CFO Ernst Teunissen projected strong guidance for the rest of the year. The firm reported EPS of $0.30 on top of $378.0 million in revenue. Wall Street expected $0.16 per share on $360.84 million in revenue.
    Shares of Match Group (Nasdaq: MTCH) popped 3% after the company reported earnings after the bell. The dating site operator reported stronger than expected earnings and revenue figures on Tuesday. Overall, revenue jumped 36% compared to the same period in 2017. The firm also reported stronger than expected guidance. Of course, all anyone is talking about how Facebook Inc. (Nasdaq: FB) could impact the dating industry with its new plugin.
    Shares of 21st Century Fox (NYSE FOXA) are in focus as the firm prepares to report earnings before the bell. However, investors are more likely focused today on the expected bidding war between the Walt Disney Co. (NYSE: DIS) and Comcast Corporation (Nasdaq: CMCSA) to purchase key assets of the company. Fox is also tied up in a bidding war with Comcast to purchase British television provider Sky (OTC MKTS: SKYAY).
    Look for additional earnings reports from Booking Holdings (Nasdaq: BKNG), com International (Nasdaq: CTRP), Sina Corp. (Nasdaq: SINA), Albermarle Corp. (NYSE: ALB), Mylan Inc. (NYSE: MYL), SolarEdge Technologies (Nasdaq: SEDG), Wolverine World Wide (NYSE: WWW), IAC Interactive Corp. (NYSE: IAC), and Cavium Inc. (Nasdaq: CAVM).

    Eight Seconds

  • [By Ethan Ryder]

    Wolverine World Wide (NYSE:WWW)’s share price gapped up prior to trading on Thursday following a better than expected earnings announcement. The stock had previously closed at $33.18, but opened at $32.32. Wolverine World Wide shares last traded at $31.45, with a volume of 29527 shares changing hands.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Wolverine World Wide (WWW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Analysts at Susquehanna upgraded Wolverine World Wide, Inc. (NYSE: WWW) from Negative to Neutral.

    Wolverine shares rose 7.21 percent to close at $31.95 on Wednesday.

  • [By Stephan Byrd]

    Wolverine World Wide (NYSE:WWW)‘s stock had its “neutral” rating restated by Buckingham Research in a research note issued to investors on Wednesday. They currently have a $32.00 target price on the textile maker’s stock. Buckingham Research’s target price would indicate a potential upside of 5.51% from the company’s current price.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion.
    SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million.
    Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million.
    Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion.
    Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion.
    Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion.
    ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion.
    Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion.
    Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million.
    Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion.
    Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion.
    Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion.
    Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion.
    Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million.
    Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion.
    Groupon, Inc. (NASDAQ: GRPN) is projected to report

Top 10 Casino Stocks To Invest In Right Now: Willis Lease Finance Corporation(WLFC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Willis Lease Finance Co. (NASDAQ:WLFC) CEO Charles F. Iv Willis sold 4,718 shares of the firm’s stock in a transaction on Tuesday, June 26th. The shares were sold at an average price of $31.19, for a total transaction of $147,154.42. Following the sale, the chief executive officer now owns 706,058 shares in the company, valued at approximately $22,021,949.02. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Top 10 Casino Stocks To Invest In Right Now: Nordic American Tankers Limited(NAT)

Advisors’ Opinion:

  • [By Rich Smith]

    Shares of oil shipper Nordic American Tankers Limited (NYSE:NAT) shot up by double digits in Monday trading, and currently occupy a berth up 13.4% as of 12:55 p.m. EDT.

  • [By Matthew DiLallo]

    That volatility has been evident at both Textainer Group Holdings Ltd.(NYSE:TGH) and Nordic American Tankers Ltd. (NYSE:NAT) in recent years. Because of that, investors need to weigh their upside in a recovering market against the downside potential before choosing either stock.

  • [By Alexander Bird]

    We’re talking 471% potential gains…

    Penny Stock Current Share Price Last Week’s Gain
    Renren Inc. (NYSE: RENN) $2.50 158.64%
    Astrotech Corp. (Nasdaq: ASTC) $4.17 132.80%
    Xenetic Biosciences Inc. (Nasdaq: XBIO) $5.58 71.95%
    Nordic American Tanker Shipping Ltd. (NYSE: NAT) $2.73 38.43%
    United States Antimony Corp. (NYSE: UAMY) $0.49 36.47%
    Soeno Therapeutics Inc. (Nasdaq: SLNO) $2.65 33.05%
    Fibrocell Science Inc. (Nasdaq: FCSC) $3.16 31.36%
    Teekay Tankers Ltd. (NYSE: TNK) $1.30 29.70%
    Neovasc Inc. (Nasdaq: NVCN) $0.04 27.30%
    Actinium Pharmaceuticals Inc. (OTCMKTS: ATNM) $0.24 25.98%

    While the gains of last week’s top penny stocks are exciting, investors who know where to look can unlock even bigger gains…

  • [By Joseph Griffin]

    Carnival (NYSE: CUK) and Nordic American Tanker (NYSE:NAT) are both consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

  • [By Ethan Ryder]

    Nordic American Tanker Ltd (NYSE:NAT) declared a quarterly dividend on Friday, April 27th, Zacks reports. Investors of record on Thursday, May 24th will be given a dividend of 0.01 per share by the shipping company on Tuesday, June 12th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend is Wednesday, May 23rd.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Nordic American Tanker (NAT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Invest In Right Now: First Connecticut Bancorp, Inc.(FBNK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Connecticut Bancorp (FBNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub downgraded shares of First Connecticut Bancorp (NASDAQ:FBNK) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning.

  • [By Logan Wallace]

    First Connecticut Bancorp (NASDAQ: FBNK) and Berkshire Hills Bancorp (NYSE:BHLB) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk.

  • [By Ethan Ryder]

    First Connecticut Bancorp (NASDAQ: FBNK) and Entegra Financial (NASDAQ:ENFC) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and risk.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Connecticut Bancorp (FBNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Wells Fargo & Company MN boosted its holdings in shares of First Connecticut Bancorp Inc (NASDAQ:FBNK) by 8.6% in the first quarter, Holdings Channel reports. The institutional investor owned 148,333 shares of the bank’s stock after purchasing an additional 11,719 shares during the quarter. Wells Fargo & Company MN’s holdings in First Connecticut Bancorp were worth $3,798,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Heal Care Stocks To Invest In Right Now

Celgene Corp. (NASDAQ:CELG) investors would probably like a few do-overs given the company’s stumbles over the past year. First, it suffered a key clinical-trial failure that forced it to ratchet back its long-term sales outlook. Then, the FDA sent it an embarrassing Refusal to File letter for its most-anticipated drug, ozanimod.

The setbacks have increased the pressure on the company to deliver a win, and fortunately, that win came in the form of positive pivotal-stage trial results for luspatercept, a drug that Celgene has licensed from Acceleron Pharma (NASDAQ:XLRN). On Thursday, the companies announced that luspatercept’s late-stage study in myelodysplastic syndromes (MDS) panned out, clearing the way for filings for approval next year. How big is this win for Celgene?

What’s going on

Luspatercept addresses chronic anemia in MDS by promoting the production of healthy red blood cells and regulating TGF-beta proteins involved in the late stages of creating red blood cells.

Top 10 Heal Care Stocks To Invest In Right Now: Computer Programs and Systems Inc.(CPSI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Millrace Asset Group Inc. acquired a new position in shares of Computer Programs & Systems, Inc. (NASDAQ:CPSI) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 45,000 shares of the company’s stock, valued at approximately $1,314,000. Millrace Asset Group Inc. owned about 0.32% of Computer Programs & Systems at the end of the most recent quarter.

  • [By Max Byerly]

    Computer Programs & Systems, Inc. (NASDAQ:CPSI) has received an average rating of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, one has given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $30.80.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Computer Programs & Systems (CPSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Computer Programs & Systems (NASDAQ: CPSI) and Perion Network Ltd Common Stock (NASDAQ:PERI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Top 10 Heal Care Stocks To Invest In Right Now: RPX Corporation(RPXC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Research Frontiers (NASDAQ: REFR) and RPX (NASDAQ:RPXC) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

  • [By Logan Wallace]

    Thompson Siegel & Walmsley LLC lifted its position in RPX Co. (NASDAQ:RPXC) by 32.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 787,377 shares of the business services provider’s stock after purchasing an additional 192,430 shares during the period. Thompson Siegel & Walmsley LLC owned about 1.58% of RPX worth $8,417,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    RPX (NASDAQ:RPXC) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday.

  • [By Dan Caplinger]

    Patent litigation abuse is a major problem in the tech industry, and policymakers have looked for ways to fight it. RPX (NASDAQ:RPXC) came up with a unique approach to patent protection involving purchases of various intellectual property to deter would-be plaintiffs from challenging ownership. Yet the market for those services hasn’t grown the way some had anticipated, and even after diversifying into legal discovery services, RPX saw little choice but to start pursuing strategic alternatives to come up with a future direction for its business.

Top 10 Heal Care Stocks To Invest In Right Now: Hertz Global Holdings Inc(HTZ)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news stories that may have effected Accern’s rankings:

    Get Hertz Global alerts:

    Trending Most Active Stock: Hertz Global Holdings, Inc. (HTZ) (nasdaqplace.com) Why is the 200 Simple Moving Average (SMA) so common for traders and analysts? Novavax, Inc. (NASDAQ:NVAX … (thestreetpoint.com) Hertz Global Holdings, Inc. (HTZ): That’s where you can keep the ball in your court (fintelegraph.com) Is Hertz Global Holdings Inc (NYSE:HTZ) A Financially Sound Company? (finance.yahoo.com) Hertz Global Hol Rises 1.95% on Heavy Volume: Watch For Potential Pullback (mysmartrend.com)

    A number of brokerages have commented on HTZ. ValuEngine upgraded shares of Hertz Global from a “hold” rating to a “buy” rating in a report on Thursday, June 7th. Zacks Investment Research downgraded shares of Hertz Global from a “hold” rating to a “sell” rating in a report on Tuesday, May 15th. Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $15.71.

  • [By Demitrios Kalogeropoulos]

    Hertz Global Holdings(NYSE:HTZ) shed 31% last month compared to a 2% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Dan Caplinger]

    Wall Street had another good session on Tuesday, with favorable earnings reports from some of the nation’s most successful technology companies helping to lift major benchmarks by 1% or more. Investors haven’t forgotten about some of the potential pitfalls that could derail the recovery, including both geopolitical and macroeconomic concerns. Yet traders seem to want to see the market test its all-time highs before deciding whether the correction could turn into a full-fledged bear market reversal. Some individual stocks, however, missed out on the good times. GoPro (NASDAQ:GPRO), Apellis Pharmaceuticals (NASDAQ:APLS), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern’s rankings:

    Get Hertz Global alerts:

    Hertz Global Holdings, Inc (HTZ) CFO Thomas C. Kennedy Buys 15,000 Shares (americanbankingnews.com) Northcoast Research Weighs in on Hertz Global Holdings, Inc’s Q2 2018 Earnings (HTZ) (americanbankingnews.com) Hertz Global Target of Unusually High Options Trading (HTZ) (americanbankingnews.com) Edited Transcript of HTZ earnings conference call or presentation 8-May-18 12:00pm GMT (finance.yahoo.com) Hertz Sweeps 2018 FlyerTalk Awards (finance.yahoo.com)

    Several equities research analysts have issued reports on HTZ shares. Zacks Investment Research upgraded Hertz Global from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Macquarie upgraded Hertz Global from a “neutral” rating to an “outperform” rating in a research report on Thursday, January 18th. Goldman Sachs dropped their target price on Hertz Global from $15.00 to $13.00 and set a “sell” rating on the stock in a research report on Thursday, February 15th. Finally, ValuEngine downgraded Hertz Global from a “hold” rating to a “sell” rating in a research report on Thursday, February 15th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $15.71.

Top 10 Heal Care Stocks To Invest In Right Now: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After disclosing that the Food and Drug Administration is asking for more information before signing off on a phase 1 study of its “Sleeping Beauty” CAR-T for leukemia and lymphoma, shares in Ziopharm Oncology (NASDAQ:ZIOP) were tumbling 17.7% at 3 p.m. EDT today.

  • [By George Budwell]

    Shares of the clinical-stage biotech Ziopharm Oncology (NASDAQ:ZIOP) rose by a healthy 16% last month,according toS&P Global Market Intelligence. What sparked this sizable rally?

  • [By Keith Speights]

    If you like putting money into the beaten-down stocks of clinical-stage biotechs, Ziopharm Oncology (NASDAQ:ZIOP) and Celldex Therapeutics (NASDAQ:CLDX) might warrant a look. Ziopharm’s share price has dropped more than 25% so far in 2018, while Celldex stock has plunged more than 80%.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top 10 Heal Care Stocks To Invest In Right Now: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday was a calm day on Wall Street, with several major benchmarks posting modest gains while others stayed closer to the unchanged mark. Market participants generally seemed ready to take a pause in trends over the past several days, as crude oil prices bounced back from their recent drop to climb above $65 per barrel while interest rates eased slightly lower. Yet despite a resilient market that largely avoided most downward pressure, some individual stocks weren’t as lucky. Carnival (NYSE:CCL) (NYSE:CUK), Tarena International (NASDAQ:TEDU), and Genesco (NYSE:GCO) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results.

  • [By Max Byerly]

    K12 (NYSE: LRN) and Tarena International (NASDAQ:TEDU) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

  • [By Logan Wallace]

    Tarena International (NASDAQ: TEDU) and Aspen Group (NASDAQ:ASPU) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

  • [By Ethan Ryder]

    Tarena International (NASDAQ: TEDU) and TAL Education (NYSE:TAL) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Top 10 Heal Care Stocks To Invest In Right Now: Leggett & Platt, Incorporated(LEG)

Advisors’ Opinion:

  • [By Logan Wallace]

    California Public Employees Retirement System boosted its stake in shares of Leggett & Platt, Inc. (NYSE:LEG) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 413,255 shares of the company’s stock after purchasing an additional 10,689 shares during the period. California Public Employees Retirement System owned about 0.31% of Leggett & Platt worth $18,332,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Leggett & Platt (NYSE: LEG) and Hooker Furniture (NASDAQ:HOFT) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Leggett & Platt (LEG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Candriam Luxembourg S.C.A. decreased its position in shares of Leggett & Platt, Inc. (NYSE:LEG) by 7.6% in the 1st quarter, HoldingsChannel reports. The fund owned 39,994 shares of the company’s stock after selling 3,289 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Leggett & Platt were worth $1,774,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Shares of LEG Immobilien AG (FRA:LEG) have been assigned an average rating of “Buy” from the nineteen research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is €101.62 ($118.16).

Top 10 Heal Care Stocks To Invest In Right Now: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Shane Hupp]

    Aimmune Therapeutics (NASDAQ:AIMT)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued to clients and investors on Wednesday. They currently have a $72.00 target price on the biotechnology company’s stock. Wedbush’s price objective points to a potential upside of 117.59% from the company’s previous close.

  • [By ]

    Aimmune Therapeutics (AIMT) : “I do like it. That’s an important niche business. “

    Ingersoll-Rand (IR) : “I like Ingersoll-Rand. They work well at this phase in the cycle.”

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.13, with a consensus price target of $55.50 and a 52-week range of $15.97 to $40.65.

  • [By ]

    In the Lightning Round, Cramer was bullish on Ingersoll-Rand (IR) , The Blackstone Group (BX) , Thermo Fisher Scientific (TMO) , FMC Corp (FMC) , Nike (NKE) , Zebra Technologies (ZBRA) and Aimmune Therapeutics (AIMT) .

Top 10 Heal Care Stocks To Invest In Right Now: Bravo Brio Restaurant Group Inc.(BBRG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media coverage about Bravo Brio Restaurant Group (NASDAQ:BBRG) has trended positive on Saturday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bravo Brio Restaurant Group earned a daily sentiment score of 0.39 on Accern’s scale. Accern also assigned media coverage about the restaurant operator an impact score of 45.847415840944 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Heal Care Stocks To Invest In Right Now: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania. “

  • [By Stephan Byrd]

    Headlines about Aclaris Therapeutics (NASDAQ:ACRS) have been trending somewhat positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aclaris Therapeutics earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the biotechnology company an impact score of 46.9638334424702 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Aclaris Therapeutics (NASDAQ:ACRS) received a $50.00 price target from equities research analysts at Cantor Fitzgerald in a report issued on Tuesday. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 177.62% from the company’s current price.

Top 10 Heal Care Stocks To Invest In Right Now: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cherokee (NASDAQ:CHKE) released its quarterly earnings data on Thursday. The company reported ($0.20) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.11), RTT News reports. Cherokee had a negative return on equity of 13.63% and a negative net margin of 130.24%. During the same quarter last year, the business posted ($0.07) earnings per share.

  • [By Garrett Baldwin]

    Following the June FOMC meeting, silver prices are hovering at very attractive price levels. With interest rates heading higher, it’s going to be a very good time for silver hounds to buy on the dip and deliver incredible profits in the months ahead.Learn more right here.

    The Top Stock Market Stories for Thursday
    On Thursday, the European Central Bank held its meeting in Latvia to discuss the future of its quantitative easing program. The central bank of the world’s largest economic bloc said that it will likely end its quantitative easing program in December. This represents an extension beyond the current plan to end the stimulus program in September. ECB President Mario Draghi said the program would be reduced to 15 billion euros each month during the final three months of the year. Yesterday, the U.S. Federal Reserve raised interest rates for the second time in 2018. The central bank said that economic growth has been rising at a solid rate and hinted that it could raise rates two more times this year. Fed Chair Jerome Powell did raise an alarm on Wednesday after stating that companies are holding back on investment due to ongoing concerns about U.S. President Donald Trump’s trade policies. Trump is expected to decide this week on whether to proceed with tariffs on about $50 billion in Chinese goods. Trade tensions are heating up again. This morning, China announced it would call off its deal to avoid a trade war if the Trump administration proceeds with tariffs on Friday morning. Tomorrow, the Trump team will decide if it will hit China with tariffs on roughly $50 billion in goods.
    Stocks to Watch Today: ADBE, CMCSA, TSLA, MSFT
    Adobe Systems Inc. (Nasdaq: ADBE) will report earnings after the bell Thursday. The software giant is expected to report earnings per share of $1.54 on top of $2.15 billion in revenue. Insider buying is alive and well at Tesla Inc. (Nasdaq: TSLA). Chair and CEO Elon Musk purchased $25 million in company stock, according to a

  • [By Max Byerly]

    Cherokee (NASDAQ: CHKE) and J.Jill (NYSE:JILL) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top 5 Performing Stocks To Own For 2018

Bank of America’s (NYSE:BAC) shares suddenly dropped last week, slumping ~6 percent on Tuesday as investors rushed to sell financials and take profits in stocks that have soared since the U.S. election. Republicans also don’t appear to be able to score legislative victories as easily as investors thought, which raises concerns over the sustainability of the Trump rally.

Let’s first agree that Bank of America has been a very good investment already in the last several months, but especially over the last year. Believe it or not, but an investment in Bank of America has returned ~70 percent since March 28, 2016, outperforming other financial stocks as well as major stock market indices by a wide margin.

Top 5 Performing Stocks To Own For 2018: Dave & Buster's Entertainment, Inc.(PLAY)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY)updated guidance for its fiscal 2017 (which ends on February 4, 2018):

  • [By Stephan Byrd]

    Equities analysts expect Dave & Buster’s (NASDAQ:PLAY) to report $324.81 million in sales for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Dave & Buster’s’ earnings, with estimates ranging from $320.19 million to $332.00 million. Dave & Buster’s posted sales of $304.15 million during the same quarter last year, which suggests a positive year over year growth rate of 6.8%. The firm is scheduled to report its next quarterly earnings report on Tuesday, June 5th.

  • [By Trey Thoelcke]

    Dave & Buster’s Entertainment Inc.’s (NASDAQ: PLAY) fiscal fourth-quarter report is scheduled for Tuesday after the markets close. The consensus estimates are $0.60 in earnings per share (EPS) on $305.49 million in revenue. The shares ended the week at $41.74. The consensus price target is $65.33, and the 52-week trading range is $41.04 to $73.48.

  • [By Matt Hogan]

    Casual-dining chains have not been winners during this economic expansion. Millenials, with their need for more social media-worthy experiences, have been blamed for the decline in conjunction with Baby Boomers moving onto fixed incomes as they retire.

    Dave & Buster's Entertainment Inc (NASDAQ: PLAY) provides an eat, drink, play, and watch experience for consumers. This hybrid entertainment/dining experience has fared well since going public in 2012, attracting higher-income adults in the 21-39 age range.
    Poor same-store sales last quarter knocked the premium off the stock price, but top and bottom-line growth were still strong. Margins and efficiency ratios top its competitors, and Wall Street and quant valuation models agree that there is a strong upside for this diamond in the casual-dining rough.

    You'll Probably Want to Sit Down for This

    Casual dining, the traditional sit-down, full-service restaurant experience is getting hit by demographics. Millennials want hip, social-media worthy experiences and retiring Baby Boomers are thrifty on their fixed incomes. Headlines such as "Millennials Are Killing Chains Like Buffalo Wild Wings And Applebee's" are not uncommon.

Top 5 Performing Stocks To Own For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top 5 Performing Stocks To Own For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Todd Campbell]

    It garnered a lot of attention in 2015 when Ziopharm (NASDAQ:ZIOP) announced it would use its “sleeping beauty” technology to improve upon chimeric antigen receptor T-cell therapies that it was developing. Then, its mosquitoes that are engineered so that they can’t reproduce and spread disease won investor interest during the Zika virus outbreak in 2015 and 2016.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

Top 5 Performing Stocks To Own For 2018: NF Energy Saving Corporation(NFEC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 5 Performing Stocks To Own For 2018: China Petroleum & Chemical Corporation(SNP)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Sinopec (NYSE:SNP) have been trending somewhat positive on Saturday, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sinopec earned a coverage optimism score of 0.23 on Accern’s scale. Accern also gave headlines about the oil and gas company an impact score of 45.9265677546286 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Sinopec (NYSE:SNP) announced a Semi-Annual dividend on Wednesday, March 28th, Zacks reports. Investors of record on Friday, May 25th will be paid a dividend of 4.568 per share by the oil and gas company on Thursday, June 21st. The ex-dividend date is Thursday, May 24th.

fixed income investments

Can the Trump Stock Rally Last?

Bob Rodriguez: Trump Might Be Acting; Huge Financial Crisis Still Looming

Why Former Reagan Official Stockman Sees a Huge Trump Correction

As investors pile into index-based funds to chase lower fees, one fund research group is sharing its view on what that choice means for investors over time, and the results should surprise both advisors and their clients.

In the longer term, Dalbar says, active investments have produced better results, which reflects investors’ tendency to stay in these funds for longer periods of time.

It also highlights the relative “closeness” of the different performance results of active and passive funds, which suggests that investors and advisors should look beyond investment characteristics and “always include situational factors applicable” to individual investors. 

The following 12 features should be considered (along with costs) when picking active and passive funds, according to Dalbar:

fixed income investments: Oceaneering International, Inc.(OII)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Oceaneering International (NYSE:OII) warned investors earlier this year that 2018 would be a challenging one. The offshore service and product company also thought that the first quarter would be particularly tough because it’s a seasonally weaker quarter. While itdidn’t go exactly as the company envisioned, the results met its muted expectations overall.

  • [By Ethan Ryder]

    Oceaneering International (NYSE:OII) was the recipient of some unusual options trading activity on Monday. Stock traders purchased 833 put options on the stock. This is an increase of approximately 1,415% compared to the average daily volume of 55 put options.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Oceaneering International (OII)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Cypress Energy Partners (NYSE: CELP) and Oceaneering International (NYSE:OII) are both oils/energy companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, institutional ownership, earnings and profitability.

fixed income investments: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    FibroGen (NASDAQ:FGEN) Director Jorma Routti sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $47.10, for a total transaction of $282,600.00. Following the completion of the transaction, the director now directly owns 133,840 shares in the company, valued at approximately $6,303,864. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

fixed income investments: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Todd Campbell]

    It garnered a lot of attention in 2015 when Ziopharm (NASDAQ:ZIOP) announced it would use its “sleeping beauty” technology to improve upon chimeric antigen receptor T-cell therapies that it was developing. Then, its mosquitoes that are engineered so that they can’t reproduce and spread disease won investor interest during the Zika virus outbreak in 2015 and 2016.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

fixed income investments: Empire State Realty Trust, Inc.(ESRT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Prudential Financial Inc. cut its stake in Empire State Realty (NYSE:ESRT) by 0.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,745,889 shares of the real estate investment trust’s stock after selling 8,046 shares during the quarter. Prudential Financial Inc.’s holdings in Empire State Realty were worth $29,313,000 at the end of the most recent quarter.

  • [By ]

    Empire State Realty Trust (ESRT) : “The yield on this one is too low.”

    DowDuPont (DWDP) : “I’m not running away, I’m sticking with them.”

  • [By ]

    For example, nobody is going to come along and build another Empire State Building. In fact, you can actually invest in this building through the Empire State Realty Trust (NYSE: ESRT).

fixed income investments: EP Energy Corporation(EPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the energy shares rose 0.76 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 59 percent, and EP Energy Corporation (NYSE: EPE) up 7 percent.

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)
  • [By Lisa Levin]

    Wednesday afternoon, the energy shares climbed 1.59 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 77 percent, and EP Energy Corporation (NYSE: EPE), up 19 percent.

  • [By Lisa Levin] Gainers
    athenahealth, Inc. (NASDAQ: ATHN) shares climbed 23.2 percent to $155.19 after Elliott Management confirmed a $160 per share cash offer for athenahealth.
    Evolus, Inc. (NASDAQ: EOLS) gained 21.3 percent to $8.83. Evolus named David Moatazedi as new CEO.
    VivoPower International PLC (NASDAQ: VVPR) climbed 18.2 percent to $3.12 after falling 39.86 percent on Friday.
    Gramercy Property Trust (NYSE: GPT) rose 15.6 percent to $27.53 after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    EP Energy Corporation (NYSE: EPE) rose 13 percent to $2.26.
    Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) gained 11.9 percent to $7.35.
    National CineMedia, Inc. (NASDAQ: NCMI) surged 11.8 percent to $6.24 after the company posted upbeat quarterly profit.
    Sanchez Energy Corporation (NYSE: SN) shares gained 11.3 percent to $3.56.
    CVR Refining, LP (NYSE: CVRR) shares rose 8.8 percent to $18.875.
    Monaker Group, Inc. (NASDAQ: MKGI) rose 8.7 percent to $2.9683.
    Kosmos Energy Ltd. (NYSE: KOS) shares rose 7.4 percent to $7.40.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 7 percent to $2.88 after climbing 1.89 percent on Friday.
    Cloudera, Inc. (NYSE: CLDR) surged 6 percent to $15.93. Craig-Hallum initiated coverage on Cloudera with a Buy rating.
    Illumina, Inc. (NASDAQ: ILMN) rose 5.1 percent to $257.35. Barclays upgraded Illumina from Equal-Weight to Overweight.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin]

    On Wednesday, the energy shares climbed 1.48 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 15 percent, and EP Energy Corporation (NYSE: EPE), up 15 percent.

fixed income investments: Nemaska Lithium Inc. (NMKEF)

Advisors’ Opinion:

  • [By ]

    Over the past two months, Nemaska Lithium (OTCQX:NMKEF) has steadily been updating the market on its half-billion-dollar-plus financial raise. The company has aggressively set targets to build out a vertically integrated lithium mining and processing operation ideally positioned to meet growing demand in North America and Europe.

  • [By ]

    Canadian hard-rock lithium chemicals company Nemaska Lithium (OTCQX:NMKEF) is presently at the end of completing a $500 million capital raise which will allow the company to expand into Phase 2 production of the its facility in Quebec. The company has closed an equity deal valued at nearly $100 million from Japans SoftBank (OTCPK:SFTBY), executed a streaming agreement with Orion Mine Finance LF valued at over $150 million, and engaged with such high-quality financial groups including Clarkson Platou Securities and Pareto Securities as managers of the bond issuance. Further, Nemaska has signed multiple offtake agreements, including NorthVolt, FMC, Softbank and Johnson Matthey Battery Materials, for the purchase of its lithium chemicals once production begins.